U.S. flag

An official website of the United States government

NM_000536.4(RAG2):c.1375A>C (p.Met459Leu) AND Histiocytic medullary reticulosis

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jun 1, 2025
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001834862.2

Allele description [Variation Report for NM_000536.4(RAG2):c.1375A>C (p.Met459Leu)]

NM_000536.4(RAG2):c.1375A>C (p.Met459Leu)

Gene:
RAG2:recombination activating 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p12
Genomic location:
Preferred name:
NM_000536.4(RAG2):c.1375A>C (p.Met459Leu)
HGVS:
  • NC_000011.10:g.36592794T>G
  • NG_007573.1:g.10443A>C
  • NG_033154.1:g.3302T>G
  • NM_000536.4:c.1375A>CMANE SELECT
  • NM_001243785.2:c.1375A>C
  • NM_001243786.2:c.1375A>C
  • NP_000527.2:p.Met459Leu
  • NP_001230714.1:p.Met459Leu
  • NP_001230715.1:p.Met459Leu
  • LRG_99:g.10443A>C
  • NC_000011.9:g.36614344T>G
  • NM_000536.3:c.1375A>C
Protein change:
M459L
Links:
dbSNP: rs1204766339
Molecular consequence:
  • NM_000536.4:c.1375A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001243785.2:c.1375A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001243786.2:c.1375A>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Histiocytic medullary reticulosis
Synonyms:
SEVERE COMBINED IMMUNODEFICIENCY WITH HYPEREOSINOPHILIA; Omenn syndrome
Identifiers:
MONDO: MONDO:0011338; MedGen: C2700553; Orphanet: 39041; OMIM: 603554

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002090400Natera, Inc.
criteria provided, single submitter

(Natera Variant Classification Schema (03/2026))
Likely pathogenic
(Jun 1, 2025)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Partial RAG deficiency in a patient with varicella infection, autoimmune cytopenia, and anticytokine antibodies.

Goda V, Malik A, Kalmar T, Maroti Z, Patel B, Ujhazi B, Csomos K, Hale JE, Chen K, Bleesing J, Palma P, Cancrini C, Comeau AM, Krivan G, Walter JE.

J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1769-1771.e2. doi: 10.1016/j.jaip.2018.01.015. Epub 2018 Feb 2. No abstract available.

PubMed [citation]
PMID:
29410113
PMCID:
PMC6072614

Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency.

Walter JE, Rosen LB, Csomos K, Rosenberg JM, Mathew D, Keszei M, Ujhazi B, Chen K, Lee YN, Tirosh I, Dobbs K, Al-Herz W, Cowan MJ, Puck J, Bleesing JJ, Grimley MS, Malech H, De Ravin SS, Gennery AR, Abraham RS, Joshi AY, Boyce TG, et al.

J Clin Invest. 2015 Nov 2;125(11):4135-48. doi: 10.1172/JCI80477. Epub 2015 Oct 12. Erratum in: J Clin Invest. 2016 Nov 1;126(11):4389. doi: 10.1172/JCI91162..

PubMed [citation]
PMID:
26457731
PMCID:
PMC4639965
See all PubMed Citations (3)

Details of each submission

From Natera, Inc., SCV002090400.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

The c.1375A>C variant in RAG2 is a missense variant predicted to cause substitution of methionine to leucine at amino acid 459. This variant is rare in the general population with a frequency below the threshold expected for the associated phenotype(s). This variant has been observed in one or more individuals affected with the associated recessive disease, as either homozygous or compound heterozygous with a second variant (PMID: 29410113, 26457731, 22841008). Additionally, this variant has been observed to segregate in affected family members (PMID: 22841008). Functional studies show that this variant may disrupt protein function (PMID: 22841008). Computational prediction algorithms indicate this variant is likely to affect gene or protein function. Given the available evidence, this variant is classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 12, 2026

Modify your search Search (all fields optional) Clear all
Advanced Search